Numerous in vivo preclinical studies of hypertension and heart failure demonstrated an upregulation of RAMP1 and/or CGRP expression in pathological conditions, indicating a cardioprotective role of CGRP (5, 8–10). Here, RAMP1 is linked to heart failure.